Latest News about Johnson & Johnson
Recent news which mentions Johnson & Johnson
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
March 13, 2024
From CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
From CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
From CNBC.com News
The U.S. has no federal bereavement leave. What to know about options at work when someone you love dies
January 26, 2024
From CNBC.com News
Treasury yields fall ahead of economic growth numbers
January 25, 2024
From CNBC.com News
From CNBC.com News
Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
January 23, 2024
From CNBC.com News
5 things to know before the stock market opens Tuesday
January 23, 2024
From CNBC.com News
Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
January 23, 2024
From CNBC.com News
Treasury yields fractionally higher ahead of key data releases
January 23, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
January 22, 2024
From CNBC.com News
Treasury yields retreat ahead of big week for economic data
January 22, 2024
From CNBC.com News
From CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
From CNBC.com News
Jim Cramer compares NFL playoffs teams to stock picks
January 12, 2024
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
From CNBC.com News
Jim Cramer examines the Dow's best and worst performers of 2023
January 02, 2024
From CNBC.com News
Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensive
December 28, 2023
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
From CNBC.com News
10-year Treasury yield falls slightly on shorter trading day
December 22, 2023
From CNBC.com News
10-year Treasury yield falls as investors continue to assess path ahead for rate cuts
December 21, 2023
From CNBC.com News
Treasury yields dip slightly as Fed trajectory remains in focus
December 20, 2023
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.